Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Total Liabilities: 2020-2022

Historic Total Liabilities for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to $10.1 million.

  • Terns Pharmaceuticals' Total Liabilities rose 49.15% to $13.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $13.3 million, marking a year-over-year increase of 49.15%. This contributed to the annual value of $10.1 million for FY2022, which is 29.82% up from last year.
  • As of FY2022, Terns Pharmaceuticals' Total Liabilities stood at $10.1 million, which was up 29.82% from $7.8 million recorded in FY2021.
  • Terns Pharmaceuticals' Total Liabilities' 5-year high stood at $23.7 million during FY2020, with a 5-year trough of $7.8 million in FY2021.
  • Moreover, its 3-year median value for Total Liabilities was $10.1 million (2022), whereas its average is $13.8 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first slumped by 67.23% in 2021, then rose by 29.82% in 2022.
  • Over the past 3 years, Terns Pharmaceuticals' Total Liabilities (Yearly) stood at $23.7 million in 2020, then slumped by 67.23% to $7.8 million in 2021, then increased by 29.82% to $10.1 million in 2022.